These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 4297801)

  • 1. The antiarrhythmic properties of ICI 46037, a quaternary analog of propranolol.
    Lucchesi BR; Iwami T
    J Pharmacol Exp Ther; 1968 Jul; 162(1):49-59. PubMed ID: 4297801
    [No Abstract]   [Full Text] [Related]  

  • 2. The antiarrhythmic properties of UM-272, the dimethyl quaternary derivative of propranolol.
    Schuster DP; Lucchesi BR; Nobel NL; Mimnaugh MN; Counsell RE; Kniffen FJ
    J Pharmacol Exp Ther; 1973 Jan; 184(1):213-27. PubMed ID: 4405548
    [No Abstract]   [Full Text] [Related]  

  • 3. The antiarrhythmic effects of quaternary salts of beta-adrenergic blocking agents.
    Lahiri PK; Hardman HF
    Arch Int Pharmacodyn Ther; 1974 Aug; 210(2):197-211. PubMed ID: 4155279
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiarrhythmic and electrophysiologic properties of UM-272, dimethyl quaternary propranolol, in the canine heart.
    Kniffen FJ; Schuster DP; Lucchesi BR
    J Pharmacol Exp Ther; 1973 Nov; 187(2):260-8. PubMed ID: 4356014
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anti-arrhythmic effects of a beta-adrenolytic agent dl (hydroxy 2't-butylamino-3' propyloxy) 8-thiochromane (S 2395)].
    Laubie M; Cheymol G; Mouillé P; Gilbert JC; Schmitt H
    Arch Int Pharmacodyn Ther; 1973 Feb; 201(2):323-33. PubMed ID: 4146788
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiarrhythmic activity of bunolol, a new beta adrenergic blocking agent.
    Kaplan HR; Robson RD
    J Pharmacol Exp Ther; 1970 Oct; 175(1):168-77. PubMed ID: 4394302
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanism of action of dimethyl quaternary propranolol (UM-272) in isoproterenol-induced cardiomyopathy in rats.
    Gupta M; Seth SD; Gupta MP; Manchanda SC
    Indian J Med Res; 1983 Jun; 77():886-94. PubMed ID: 6642587
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-arrhythmic properties of 1,5-dimorpholino-3-(1-naphthyl)-pentane (DA 1686).
    Bianchi C; Sanna GP; Turba C
    Arzneimittelforschung; 1968 Jul; 18(7):845-50. PubMed ID: 5755831
    [No Abstract]   [Full Text] [Related]  

  • 9. The cardioactive and related properties of N-methyl-N-( -phenylethyl)-1,2,3,4-tetrahydro-6-methoxy-4,4-dimethyl-2-naphthylamine hydrochloride (2-AT-1).
    Graeff DM; Johnson WE; Martin AR
    Arch Int Pharmacodyn Ther; 1971 Sep; 193(1):134-48. PubMed ID: 4398737
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparison of the anti-arrhythmia and local anesthetizing actions of some substances].
    Diadiura ZhA; L'vov MV
    Farmakol Toksikol; 1975; 38(2):170-3. PubMed ID: 1227882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cellular mechanism of the antiarrhythmic action of propranolol].
    Kwiatkowska B; Czarnecka M; Lewartowski B
    Acta Physiol Pol; 1970; 21(4):441-54. PubMed ID: 5452921
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative myocardial depressant and anti-arrhythmic properties of d-propranolol, dl-propranolol and quinidine.
    Parmley WW; Braunwald E
    J Pharmacol Exp Ther; 1967 Oct; 158(1):11-21. PubMed ID: 6054071
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular effects of atelopidtoxin.
    Ranney BK; Fuhrman GJ; Fuhrman FA
    J Pharmacol Exp Ther; 1970 Nov; 175(2):368-76. PubMed ID: 4320451
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antifibrillatory properties of new alkoxynaphthoic acid-esters in comparison with quinidine and procaine amide].
    Igarashi T; Hashimoto N
    Arzneimittelforschung; 1968 Oct; 18(10):1274-8. PubMed ID: 5755706
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiarrhythmic effect of some naphthylalkylamine derivatives.
    Hadházy P; Kecskeméti V; Vizi ES; Illés P
    Acta Physiol Acad Sci Hung; 1968; 33(2):185-95. PubMed ID: 5679793
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antiarrhythmic effect of butidrine: experimental study on arrhythmias induced by N-adrenaline in halothane anesthesia].
    Rossano C; Romoli M; Brunozzi LT; Monti GB; Pavoni P
    Acta Anaesthesiol; 1969; 20(4):663-700. PubMed ID: 4397385
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiarrhythmic activity of TR 2985, a novel diphenylhydantoin derivative.
    Vidrio H; Mena MA; Hong E
    Arzneimittelforschung; 1980; 30(1):12-7. PubMed ID: 7378162
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacology of dl-5-methyl-8-(2-hydroxy-3-t-butylaminopropoxy) coumarin hydrochloride (CS-359), a new beta-adrenergic blocking agent.
    Oshima T; Kumakura S; Koike H; Nakayama K
    Jpn J Pharmacol; 1973 Aug; 23(4):497-513. PubMed ID: 4148384
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacological actions of 1-(o-methoxyphenoxy)3-isopropylamino-2-propanol hydrochloride (S-D-1601), a new beta-blocking agent.
    Ferrini R; Miragoli G; Croce G
    Arzneimittelforschung; 1970 Aug; 20(8):1074-9. PubMed ID: 4394830
    [No Abstract]   [Full Text] [Related]  

  • 20. Propranolol (Inderal) in experimentally-induced cardiac arrhythmias.
    Lucchesi BR; Whitsitt LS; Brown NL
    Can J Physiol Pharmacol; 1966 Jul; 44(4):543-7. PubMed ID: 5966564
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.